Not available
Quote | Natera Inc. (NASDAQ:NTRA)
Last: | $110.70 |
---|---|
Change Percent: | 0.59% |
Open: | $107.17 |
Close: | $110.70 |
High: | $111.79 |
Low: | $107 |
Volume: | 1,057,391 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Natera Inc. (NASDAQ:NTRA)
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that its latest research and data on prenatal and reproductive genetics will be presented at the 28th International Conference on Prenatal Diagnosis and Therapy. Hosted by the Internationa...
2024-06-27 10:17:45 ET Information Technology has been the best performing name among all 11 S&P 500 ( SP500 ) sectors in the first half of 2024, but Cathie Wood’s actively managed ARK Innovation ETF ( NYSEARCA: ARKK ) - which aims to provide investors exposure to dis...
Message Board Posts | Natera Inc. (NASDAQ:NTRA)
Subject | By | Source | When |
---|---|---|---|
znewcar1: NTRA 21% v2,9M c43.51 f78,6M HH43.81 gap up dipped below VWAP S@40.2 | znewcar1 | investorshangout | 05/08/2020 12:29:43 AM |
News, Short Squeeze, Breakout and More Instantly...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that its latest research and data on prenatal and reproductive genetics will be presented at the 28th International Conference on Prenatal Diagnosis and Therapy. Hosted by the Internationa...
First-of-its-kind study in gastroesophageal adenocarcinoma using Signatera to guide treatment and assess the efficacy of a novel HER2-directed adjuvant treatment Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced a new gastroes...
2024-06-23 13:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...